GO
Loading...

GlaxoSmithKline PLC

More

  • SHANGHAI, March 16- Japan's Nikon Corp has moved to allay consumer fears in China after being criticised on a closely watched consumer show that said the camera maker had sold defective products in China and denied local consumers fair treatment in aftersales service.

  • *Market leader Abbott, others still investing in India. *GlaxoSmithKline spends $1 bln to raise India unit stake. The two top foreign players, Abbott Laboratories and GlaxoSmithKline Plc, are actually stepping up investment, and others such as AstraZeneca Plc are considering doing so.

  • SAN FRANCISCO, March 10- A U.S. appeals court ruling that significantly boosted gay rights will stand, as a pharmaceutical company involved in the case said on Monday that it would not appeal.

  • LONDON, March 10- GlaxoSmithKline said on Monday it had paid 64 billion rupees to increase its stake in its Indian pharmaceuticals unit to 75 percent, as it banks on rising demand for medicines in emerging markets. Britain's biggest drugmaker first announced plans to lift the holding in GlaxoSmithKline Pharmaceuticals from 50.7 percent in December.

  • FRANKFURT, Feb 27- Bayer said it would buy privately held Dihon Pharmaceutical Group Co, a maker of traditional herbal Chinese medicines, as the German drugmaker pushes to become the world's largest non-prescription medicines group.

  • *Aegon gains 4 pct, Vodafone rises 1.7 pct. LONDON, Feb 21- European shares edged higher in cautious trading on Friday, with France's CAC 40 hitting a 5-1/ 2- year peak as investors took their lead from gains on Wall Street and in Asia after robust U.S. factory data.

  • *Vodafone rises 2.8 pct, top gainer. LONDON, Feb 21- European shares climbed higher on Friday, with France's CAC 40 hitting a 5-1/ 2- year peak, as investors took their lead from stronger equities on Wall Street and in Asia following robust U.S. factory data. France's CAC was up 0.1 percent after hitting a level not seen since 2008..

  • NEW YORK/ LONDON, Feb 19- A handful of consumer and healthcare companies including Bayer AG and Novartis are exploring a deal for Merck& Co Inc's consumer healthcare business, as they seek to gain scale in a fragmented industry, according to several people familiar with the matter.

  • *Qualcomm's Beijing headquarters raided in November. BEIJING, Feb 19- China's anti-monopoly regulator on Wednesday said Qualcomm Inc. was suspected of overcharging and abusing its market position, allegations which could see the U.S. chip giant hit with record fines of more than $1 billion.

  • Early movers: KO, FRX, WM, MDT, NFLX, TSLA & more Tuesday, 18 Feb 2014 | 8:08 AM ET

    Some of the names on the move ahead of the open.

  • But in January 2012 an old business acquaintance was ready to go public with accusations of widespread mortgage fraud at Bank of America's Countrywide unit, and he turned to Wasinger.

  • Buffett's Berkshire trims some stock stakes Friday, 14 Feb 2014 | 6:09 PM ET
    Warren Buffett

    The company eliminated its holdings of Dish Network and GlaxoSmithKline, and trimmed its holdings in several other names.

  • Finding reason to invest in India amid BRIC slide Friday, 14 Feb 2014 | 8:00 AM ET
    Mumbai, India

    There seems to be little to no interest in fresh overseas investment into India, and that’s a mistake, says a local expert.

  • *Wellness is "major, major platform of growth"- Nestle CEO. LONDON, Feb 13- Swiss food giant Nestle's deeper dive into healthcare by taking over the dermatology joint venture it had with L'Oreal suggests further deals in the space are likely.

  • Feb 11- The U.S. Food and Drug Administration said it will review possible heart risks associated with AstraZeneca Plc's widely-used diabetes drug saxagliptin, marketed as Onglyza and Kombiglyze XR.

  • Feb 7- The U.S. Chamber of Commerce on Friday called on the government to ratchet up pressure on India over intellectual property rights, in a move that could help prevent Indian companies from producing cheap generic versions of medicines still under patent protection.

  • Feb 7- The U.S. Chamber of Commerce on Friday called on the government to ratchet up pressure on India over intellectual property rights, in a move that could help prevent Indian companies from producing cheap generic versions of medicines still under patent protection.

  • Sanofi CEO: We underperformed in EM in 2013 Thursday, 6 Feb 2014 | 8:10 AM ET

    The CEO of Sanofi admitted the pharmaceutical giant underperformed in emerging markets last year, after reporting a decline in quarterly sales.

  • *Q4 sales $6.84 bln vs consensus $6.88 bln. *Q4 core earnings per share $1.23 vs consensus $1.16. LONDON, Feb 6- AstraZeneca expects earnings to keep falling in 2014 as generic competition to its popular heartburn and ulcer drug Nexium takes a big bite out of U.S. profits from late May.

  • MUMBAI/ LONDON, Feb 6- Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent, sources with direct knowledge of the matter said.

Most Popular Video

Wednesday, 16 Apr 2014 | 3:00 AM ET

European shares opened higher on Wednesday as better-than-expected Chinese growth data buoyed sentiment.

Wednesday, 16 Apr 2014 | 2:00 AM ET

Brady Dougan, CEO of Credit Suisse, says the bank's fixed income business is "strong", while the investment banking arm has performed well.

Tuesday, 15 Apr 2014 | 7:31 PM ET

Hiroshi Miyoshi, Mitsubishi CEO for Turkey and Central Asia, describes Turkey's appeal to Japanese firms, who invested $500 million in the emerging market last year.